Icagen -- Pfizer Pain Collaboration Reaches First-in-Man Milestones
29 juil. 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., July 29, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders, which is being...
AGTC and Icagen Announce Technology Transfer Agreement
24 juin 2010 08h00 HE
|
Icagen, Inc.
ALACHUA, Fla. and RESEARCH TRIANGLE PARK, N.C., June 24, 2010 (GLOBE NEWSWIRE) -- AGTC, a privately held company, and Icagen, Inc. (Nasdaq:ICGN) today announced the completion of an agreement for the...
Icagen Reports First Quarter 2010 Financial Results and Operational Highlights
07 mai 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 7, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2010. For...
Icagen to Report First Quarter 2010 Results on May 7, 2010
28 avr. 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 28, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2010 financial results on Friday, May 7, 2010 before the...
Icagen Provides Update Regarding Clinical Development Plans for ICA-105665
27 avr. 2010 08h35 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on clinical development plans for ICA-105665, the Company's novel drug candidate...
ICA-105665 Phase IIa Epilepsy Data to be Presented at the Tenth Eilat Conference on New Antiepileptic Drugs
21 avr. 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 21, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that results from a study of ICA-105665 in patients with photosensitive epilepsy will be...
Icagen Reports Fourth Quarter and Full Year 2009 Financial Results and Operational Highlights
30 mars 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 30, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
Icagen to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on March 30, 2010
18 mars 2010 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 18, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2009 on Tuesday,...
Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy
15 mars 2010 17h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 15, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally...
Icagen Reports Results of Phase Ib Pain Study of ICA-105665
01 mars 2010 16h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 1, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported results of its Phase Ib pain study of ICA-105665, the Company's novel orally available small...